NCT01167829View on ClinicalTrials.gov

ORAL T-8 Oral Testosterone for Male Hormonal Contraception

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

June 30, 2012

Conditions
Healthy
Interventions
DRUG

Oral Testosterone

Oral Testosterone: 300 mg, pills, three times daily Day 1 - 10 (total of 27 pills)

DRUG

Acyline

300 ug/kg injection on Day 0

Trial Locations (1)

98195

University of Washington, Seattle

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Washington

OTHER

NCT01167829 - ORAL T-8 Oral Testosterone for Male Hormonal Contraception | Biotech Hunter | Biotech Hunter